11th Annual Advances in Hematology & Oncology Fall Symposium

October 29, 2022

The practice of clinical hematology and oncology has been rapidly changing in recent years. Diseases and conditions that were previously extraordinarily difficult to manage have seen new treatment options emerge that have significantly improved clinical outcomes. 

This one-day symposium will update participants on sarcoma, myeloid malignancies, neuroendocrine carcinoma, relapse mantle cell lymphoma, renal cell carcinoma, precision medicine, breast cancer therapies and more. 

Target Audience

Physicians, Physician Assistants, Nurse Practitioners, Pharmacists, Registered Nurses

Learning Objectives

Participants who engage in this educational activity will be able to:

  • Attendees will be able to identify current evidence-based practice guidelines for topic areas presented.
  • Attendees will be able to identify current available clinical trials for potential enrollment to benefit their patients. 
  • contribute to recommendations for incorporation of techniques to increase access to quality care and increase enrollment in cancer clinical trials. This information will be reviewed by the organizers, and suggestions compiled/distributed to attendees as further feedback.
Additional information
Course summary
Available credit: 
  • 4.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 4.00 Hours of Participation
    Hours of Participation credit.
Course opens: 
09/22/2022
Course expires: 
12/31/2022
Event starts: 
10/29/2022 - 8:00am CDT
Event ends: 
10/29/2022 - 12:00pm CDT
Cost:
$0.00

7:00 – 8:00 a.m.              Check-in/View Exhibits/Breakfast

8:00 – 8:40 a.m.              Precision Medicine – Hui-Zi Chen, MD, PhD

8:40 – 9:20 a.m.              Advances in Relapsed Mantle Cell Lymphoma – Nirav Shah, MD

9:20 – 10:00 a.m.            Updates in Neuroendocrine Carcinoma – James P. Thomas, MD, PhD

10:00 – 10:15 a.m.          Break

10:15 – 10:55 a.m.          Breakout Sessions

  • Sexual Health & Breast Cancer Therapy - Jutta Deininger, DNP, WHNP
  • Practice-Changing Updates in Sarcoma – John Charlson, MD

10:55 – 11:35 a.m.          Renal Cell Carcinoma: Sequencing Therapy in 2022 – Nancy B. Davis, MD

11:35 – 12:15 p.m.          Progress in Myeloid Malignancies Case Presentations – Ehab Atallah, MD

12:15 p.m.                     Lunch/Adjourn

Hyatt Ki Center
333 Main Street
Green Bay 54301
United States
+1 (920) 432-1234

 

 

Keynote Speaker:

Nancy B. Davis, MD
VIce President for Cancer Care Network & Strategy
Associate Professor of Medicine & Urology
Vanderbilt University Medical Center
 

Guest Speakers:

Ehab Atallah, MD
Professor of Medicine
Division of Hematology & Oncology
Medical College of Wisconsin
 
John Charlson, MD
Associate Professor of Medicine
Division of Hematology & Oncology
Medical College of Wisconsin
 
Huizi Chen, MD, PhD
Assistant Professor
Division of Hematology & Oncology
Department of Medicine
Medical College of Wisconsin
 
Jutta Deininger, DNP, WHNP
Division of Hematology & Oncology
Medical College of Wisconsin
 
Nirav N. Shah, MD
Associate Professor of Medicine
Division of Hematology & Oncology
Medical College of Wisconsin
 
James P. Thomas, MD, PhD
Professor and Section Head, Solid Tumor Oncology
Associate Director of Translational Research
Medical College of Wisconsin

In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.

 

The following persons in control of content disclosed the following financial relationships which were reviewed via the MCW conflict of interest mitigation process and addressed.

 

NameCompanyRole
Nancy B. Davis, MD Merck, AstraZeneca, Bristol Myers Squibb, Roche, Pfizer, Exelixis, Gilead, Seagen Researcher
   
   
 

 

 

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 4.0 hours of participation for continuing education for allied health professionals.

 

Available Credit

  • 4.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 4.00 Hours of Participation
    Hours of Participation credit.

Price

Cost:
$0.00
Please login or register to take this course.

This course is complementary however registration is required. To register for this course click the "Take Course" button.

A link to our event portal will be emailed to all attendees on the week of October 25th to access our program.